Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes

Overview of attention for article published in New England Journal of Medicine, November 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

So far, Altmetric has seen 16 public wall posts from 13 users.

In patients with cardiovascular disease and overweight or obesity but no diabetes, semaglutide was superior to placebo in…

https://www.nejm.org/doi/full/10.1056/NEJMoa2307563?query=TOC

Full stomach concerns aside, would semaglutide preop reduce periop MACE? "In patients with preexisting cardiovascular disease…

น่าจะอ่านกันไปแล้ว เขาเอามาลง nejm เช้านี้อีกที Semaglutide and Cardiovascular Outcomes in Obesity without…

This page shows the most recent Facebook posts that mention this research output.

Click here to find out how to access more activity, including 12 additional Facebook posts.